From “Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors:

New York's Life Science Disruptors
New York’s Life Science Disruptors

Accelerator Corp. chief operating officer David Schubert (left), Petra Pharma co-founder Lewis Cantley (middle), and Lodo Therapeutics founder Sean Brady (right). Photos by Keith Spiro Photography